(19) reported that an increased LRG1 level was associated with adverse renal outcomes including a 40% decline in estimated glomerular filtration rate and end-stage renal disease in patients with T2DM, while Liu et al. The gene discussed is LRG1; the disease is stage 5 chronic kidney disease.